Mark Wilterding's most recent trade in RxSight Inc was a trade of 258,770 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 12, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| RxSight Inc | Mark Wilterding | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2026 | 258,770 | 258,770 | - | - | Stock Option (right to buy) | |
| RxSight Inc | Mark Wilterding | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2026 | 163,528 | 163,528 | - | - | Restricted Stock Unit |